[1]童玫瑰,程 千.清肠解毒方对大肠癌术后复发化疗患者〖JZ〗肿瘤标记物水平及生活质量的影响*[J].陕西中医,2020,(1):53-56.
　TONG Meigui,CHENG Qian..Analysis of Qingchang Jiedu decoction on quality of life and tumor markers of 〖JZ〗patients with recurrent colorectal cancer after postoperative chemotherapy[J].,2020,(1):53-56.
点击复制

清肠解毒方对大肠癌术后复发化疗患者〖JZ〗肿瘤标记物水平及生活质量的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年1期
页码:
53-56
栏目:
临床研究
出版日期:
2020-01-05

文章信息/Info

Title:
Analysis of Qingchang Jiedu decoction on quality of life and tumor markers of 〖JZ〗patients with recurrent colorectal cancer after postoperative chemotherapy
文章编号:
DOI:10.3969/j.issn.10007369.2020.01.014
作者:
童玫瑰1; 程 千2
1.安徽省芜湖市中医院（芜湖 241000）；2.上海交通大学附属同仁医院（上海 200336）
Author(s):
TONG Meigui; CHENG Qian.
Wuhu Hospital of Traditional Chinese Medicine in Anhui Province（Wuhu 241000）
关键词:
大肠癌; 清肠解毒方; 奥沙利铂; 卡培他滨; 化疗; 肿瘤标记物; 总生存率
Keywords:
Key words 〖WT5BZ〗〖HT5”SS〗Colorectal cancer; Qingchang Jiedu decoction; Oxaliplatin; Capecitabine; Chemotherapy; Tumor markers; Overall survival
分类号:
R735.34
文献标志码:
A
摘要:
摘 要 目的： 探讨清肠解毒方对大肠癌术后复发化疗患者的生活质量及肿瘤标记物水平的影响。方法：选取出现复发的大肠癌患者60例，随机分为观察组与对照组各30例。两组化疗方案均为奥沙利铂联合卡培他滨或者盐酸伊立替康联合卡培他滨，观察组加用清肠解毒方治疗。比较两组患者治疗前后血清CEA、AFP、CA125、CA199水平与ECOG评分变化。结果： 两组患者治疗后血清CEA、AFP、CA125、CA199水平显著低于治疗前（P＜0.05）。此外，治疗后观察组患者的血清CEA和CA199水平显著低于对照组（P＜0.05）。生活质量方面，治疗后两组患者ECOG评分均显著低于治疗前，差异有统计学意义（P＜0.05）；且观察组患者治疗后ECOG评分显著低于对照组，差异有统计学意义（P＜0.05）。结论： 清肠解毒方能够明显改善大肠癌术后化疗患者的生活质量，降低血清肿瘤标记物浓度，值得临床应用。
Abstract:
Abstract 〖WT5BZ〗〖HT5”SS〗Objective:To investigate the effect of Qingchang Jiedu decoction on the quality of life and tumor markers of postoperative chemotherapy for colorectal cancer patients.Methods:60 patients with postoperative chemotherapy for colorectal cancer recurrence were selected as study subjects,and then randomly divided into observation group and control group with 30 cases each.Both groups were treated by oxaliplatin or irinotecan hydrochloride combined with capecitabine,and the observation group was additionally treated with Qingchang Jiedu decoction.CEA,AFP,CA125,CA199 and ECOG scores were compared between the two groups after treatment.Results:The levels of CEA,AFP,CA125 and CA199 in the two groups after treatment were significantly lower than those before treatment (P＜0.05).Besides,compared with the control group,the levels of CEA and CA199E were much lower in the observation group after treatment.ECOG score of the two groups after treatment was significantly lower than that before treatment,and the difference was statistically significant (P＜0.05).After treatment,ECOG score of the observation group was significantly lower than that of the control group,and the difference was statistically significant (P＜0.05).Conclusion:Qingchang Jiedu decoction can significantly improve the quality of patients' life and the survival rate of patients via significantly reducing the concentration of tumor markers,which has a great value on clinical promotion.

参考文献/References:

[1] Chen W，Zheng R，Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016.
[2] Kuipers EJ，Grady WM，Lieberman D,et al.Colorectal cancer[J].Nat Rev Dis Primers,2015,1:15065.
[3] 王晓安，肖慧杰.结肠癌患者血清CEA、CA199水平与手术治疗半年预后的相关性[J].胃肠病学和肝病学杂志,2016,25(9):9981001.
[4] 徐 洁，周文彪，李袆萍.沙利度胺改善恶性肿瘤化疗患者生活质量研究分析[J].中华肿瘤防治杂志,2018,25(S1):177179.
[5] 李燕星，刘 媛，陈 喆，等.中药方剂联合化疗与单纯化疗比较对卵巢癌影响的系统评价[J].中国循证医学杂志,2018,18(9):958963.
[6] Sok M，Zavrl M，Greif B,et al.Objective assessment of WHO/ECOG performance status[J].Support Care Cancer,2019.
[7] 张至惠,李 沐.附子理中汤加减对脾肾阳虚型胃癌术后化疗患者血清肿瘤标志物的影响[J].陕西中医,2019,40(2):171173，177.
[8] 陈 蓉，李 淼，冀保妍，等.参芪扶正注射液联合化疗治疗非小细胞肺癌术后及对血清中Th17/Treg细胞的调节作用[J].中华中医药学刊,2018,36(8):19941997.
[9] 陈玉涛.化疗对老年消化道肿瘤患者生活质量的影响[J].医学信息,2016,29(19):4142.
[10] 唐耀能，赖志荣.紫杉醇类药物新辅助化疗治疗老年乳腺癌的疗效及不良反应观察[J].临床合理用药杂志,2018,11(19):9192.
[11] 韩 萍，胡婷婷，严明珠，等.胃癌术后化疗患者的营养状况对其生活质量及化疗不良反应的影响[J].河南医学研究,2018,27(20):36833686.
[12] 左婷婷，陈万青.中国乳腺癌全人群生存率分析研究进展[J].中国肿瘤临床,2016,43(14):639642.
[13] 刘倩欣，向 倩，张 卓，等.乳腺癌患者化疗药物不良反应情况及影响因素分析[J].中国临床药理学杂志,2018,34(4):475478.
[14] 卢艳琳，沈克平，何 萍.胃肠安方对大肠癌术后化疗患者生存质量及免疫功能的影响[J].中医学报,2014,29(8):11011104.
[15] 胡加兵.清肠解毒方联合手术治疗非特异性溃疡性结肠炎疗效观察[J].新中医,2014,46(12):6768.
[16] 王 涵，杨 娜，谭 静，等.白术化学成分、药理作用及临床应用的研究进展[J].甘肃医药,2018,37(1):2326.
[17] 张玉龙，王梦月，杨静玉，等.炙甘草化学成分及药理作用研究进展[J].上海中医药大学学报,2015,29(3):99102.
[18] 徐 磊，杨 静，吕 茜，等.健脾解毒汤对人大肠癌细胞HT29基质裂解蛋白9基因表达及蛋白分泌影响的实验研究[J].中国肿瘤外科杂志,2014,6(3):170173.
[19] 王春芳，刘光伟，费景兰.清肠解毒方内服并保留灌肠联合单重血浆置换术治疗重型肝炎19例[J].中医研究,2012,25(1):1819.
[20] 张育菁.自拟清肠解毒方灌肠辅助治疗慢加急性肝衰竭内毒素血症的临床观察[J].中国中医急症,2015,24(7):12641265.

相似文献/References:

[1]钱朱萍,陈康海.健脾消积汤辅助化疗对大肠癌术后患者免疫功能、胃肠功能及毒副反应影响[J].陕西中医,2019,(4):487.
[2]孙瑞华,蔡新生△.中医药对大肠癌的精准治疗及研究进展*[J].陕西中医,2019,(11):1653.
[3]罗 星,陈 琪.健脾消癌方联合化疗对大肠癌患者肿瘤标志物及预后的影响[J].陕西中医,2022,(9):1249.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.023]
[4]郭忠聪,龚 纯.抗癌防移片对大肠癌肝转移小鼠血清肝细胞生长因子、血管内皮生长因子表达的影响[J].陕西中医,2022,(11):1527.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.008]
　GUO Zhongcong,GONG Chun.Effect of Kang'ai Fangyi tablet on the expression of serum HGF and VEGF in mice with liver metastasis of colorectal cancer[J].,2022,(1):1527.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.008]
[5]雷 勇,杨 永,王笑民.名中医王笑民基于消燚祛瘀法治疗大肠癌便血经验[J].陕西中医,2023,(7):936.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.026]

备注/Memo

备注/Memo:
*江苏妇幼健康科研项目（F201656）
更新日期/Last Update: 2020-02-17